Regnum Corp. (RGMP)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -735.83 Thousand USD | -99.75% |
| 2021 | -368.37 Thousand USD | -213.05% |
| 2020 | -117.67 Thousand USD | -230.73% |
| 2019 | -35.58 Thousand USD | -1132.8% |
| 2018 | 3445.00 USD | 53.11% |
| 2017 | 2250.00 USD | 374.39% |
| 2016 | -820.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -179.32 Thousand USD | -42.96% |
| 2023 Q2 | - USD | 100.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 FY | -735.83 Thousand USD | -99.75% |
| 2022 Q2 | -182.97 Thousand USD | 34.09% |
| 2022 Q1 | -277.6 Thousand USD | -9.13% |
| 2022 Q3 | -160.91 Thousand USD | 12.05% |
| 2022 Q4 | -125.43 Thousand USD | 22.05% |
| 2021 Q1 | -3340.00 USD | -365.83% |
| 2021 FY | -368.37 Thousand USD | -213.05% |
| 2021 Q2 | -12.5 Thousand USD | -274.52% |
| 2021 Q4 | -254.37 Thousand USD | -159.18% |
| 2021 Q3 | -98.14 Thousand USD | -684.61% |
| 2020 FY | -117.67 Thousand USD | -230.73% |
| 2020 Q1 | -67.04 Thousand USD | -1346.16% |
| 2020 Q2 | -40.19 Thousand USD | 40.05% |
| 2020 Q4 | -717.00 USD | 92.62% |
| 2020 Q3 | -9722.00 USD | 75.81% |
| 2019 Q4 | -4636.00 USD | -5368.18% |
| 2019 FY | -35.58 Thousand USD | -1132.8% |
| 2019 Q2 | -7422.00 USD | 68.56% |
| 2019 Q1 | -23.61 Thousand USD | -124363.16% |
| 2019 Q3 | 88.00 USD | 101.19% |
| 2018 Q2 | 1385.00 USD | -22.71% |
| 2018 Q3 | 249.00 USD | -82.02% |
| 2018 FY | 3445.00 USD | 53.11% |
| 2018 Q4 | 19.00 USD | -92.37% |
| 2018 Q1 | 1792.00 USD | 377.87% |
| 2017 Q3 | 507.00 USD | -77.65% |
| 2017 Q1 | -900.00 USD | -227.27% |
| 2017 Q4 | 375.00 USD | -26.04% |
| 2017 Q2 | 2268.00 USD | 352.0% |
| 2017 FY | 2250.00 USD | 374.39% |
| 2016 Q4 | -275.00 USD | 0.0% |
| 2016 FY | -820.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 44.899% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 85.413% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 95.877% |
| Nascent Biotech, Inc. | -2.22 Million USD | 67.001% |
| Rebus Holdings, Inc. | -664 Thousand USD | -10.819% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 100.899% |
| Qrons Inc. | -643.67 Thousand USD | -14.317% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -88.884% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 98.674% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -77.105% |
| Skye Bioscience, Inc. | -13.67 Million USD | 94.618% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 98.975% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 114.972% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -181.147% |
| SQZ Biotechnologies Company | -75.82 Million USD | 99.03% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 74.186% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 52.096% |
| Mesoblast Limited | -84.14 Million USD | 99.126% |
| Marizyme, Inc. | -34.08 Million USD | 97.841% |
| Genus plc | 6.4 Million USD | 111.497% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 107.553% |
| Pharming Group N.V. | -4.87 Million USD | 84.92% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 62.958% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 20.995% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 91.188% |
| ContraFect Corporation | -56.88 Million USD | 98.707% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 83.845% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 47.515% |
| IMV Inc. | -38.67 Million USD | 98.097% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 73.251% |
| MultiCell Technologies, Inc. | -722.81 USD | -101701.995% |
| ONE Bio Corp. | 13.68 Million USD | 105.378% |
| Accustem Sciences Inc. | -3.74 Million USD | 80.359% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 98.753% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -52.327% |
| Q BioMed Inc. | -3.44 Million USD | 78.644% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 120.786% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 71.995% |
| Biomind Labs Inc. | -1 Million USD | 27.116% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 98.661% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 74.637% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 88.932% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 60.532% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -2356.714% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 95.363% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 61.925% |
| GB Sciences, Inc. | -1.42 Million USD | 48.199% |
| Alpha Cognition Inc. | -9.7 Million USD | 92.418% |
| HST Global, Inc. | -140.9 Thousand USD | -422.213% |
| CSL Limited | 3.7 Billion USD | 100.02% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 34.587% |
| Halberd Corporation | -75.05 Thousand USD | -880.46% |
| Enzolytics Inc. | -2.14 Million USD | 65.756% |
| Agentix Corp. | -1.37 Million USD | 46.358% |
| Resverlogix Corp. | -12.74 Million USD | 94.228% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 76.775% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 99.827% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 29.518% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 74.795% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 53.409% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 78.389% |
| AVAX Technologies, Inc. | 6.69 Million USD | 110.994% |
| Zenith Capital Corp. | -8.94 Million USD | 91.772% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.823% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -4123.839% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 70.031% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -329.034% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 63.296% |
| Kadimastem Ltd | -3.04 Million USD | 75.797% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 25.224% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 41.414% |
| BioStem Technologies, Inc. | -7.77 Million USD | 90.541% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -305.452% |
| LadRx Corporation | -3.82 Million USD | 80.756% |
| Cell Source, Inc. | -4.32 Million USD | 82.988% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -7.116% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -7.116% |
| NovAccess Global Inc. | -2.46 Million USD | 70.17% |
| Affymax, Inc. | -15.04 Million USD | 95.109% |
| Itoco Inc. | -919.14 Thousand USD | 19.943% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 82.639% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 34.242% |
| Mobile Lads Corp. | -554.55 Thousand USD | -32.69% |
| CytoDyn Inc. | -18.05 Million USD | 95.925% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -2823.46% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -234.352% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -30.3% |
| SYBLEU INC | -149.18 Thousand USD | -393.253% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 59.488% |
| International Stem Cell Corporation | -663 Thousand USD | -10.986% |
| Bioxytran, Inc. | -3.82 Million USD | 80.738% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1297.863% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -3517.675% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 97.971% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 54.522% |
| RenovaCare, Inc. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 76.347% |
| Neutra Corp. | -229.48 Thousand USD | -220.645% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 95.805% |
| PureTech Health plc | -146.19 Million USD | 99.497% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 96.576% |
| IXICO plc | -1.43 Million USD | 48.794% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 92.247% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 99.396% |
| CSL Limited | 3.81 Billion USD | 100.019% |
| Cellectis S.A. | -108.85 Million USD | 99.324% |